GH1 and adenoma: In this setting, somatostatin receptor ligands (SRL), which exert their action by interacting with SST, are an important class of drugs for the treatment of adenomas secreting growth hormone (GH), adrenocorticotropic hormone (ACTH), and thyroid‐stimulating hormone (TSH) [13].